2023
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer
Van Schil P, Asamura H, Nishimura K, Rami-Porta R, Kim Y, Bertoglio P, Cangir A, Donington J, Fang W, Giroux D, Lievens Y, Liu H, Lyons G, Sakai S, Travis W, Ugalde P, Yang C, Yotsukura M, Detterbeck F, Committee A. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer. Journal Of Thoracic Oncology 2023, 19: 749-765. PMID: 38070600, PMCID: PMC11081813, DOI: 10.1016/j.jtho.2023.12.006.Peer-Reviewed Original ResearchLung cancerT descriptorChest wallTNM classificationInternational Association for the Study of Lung CancerInternational Association for the Study of Lung Cancer databaseMultivariate Cox regression analysisLung Cancer Staging ProjectInclusion criteriaPathologically staged tumorsCox regression analysisTNM classification of lung cancerClassification of lung cancerDate of diagnosisStudy of Lung CancerLung cancer databaseNinth EditionPleura involvementT3 descriptorsT4 tumorsWorse survivalCancer DatabaseComprehensive survival analysisPathological typeUnivariate analysis
2016
Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma—An Analysis of the International Thymic Malignancies Interest Group Retrospective Database
Rimner A, Yao X, Huang J, Antonicelli A, Ahmad U, Korst RJ, Detterbeck F, Gomez DR. Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma—An Analysis of the International Thymic Malignancies Interest Group Retrospective Database. Journal Of Thoracic Oncology 2016, 11: 1785-1792. PMID: 27346413, PMCID: PMC5257334, DOI: 10.1016/j.jtho.2016.06.011.Peer-Reviewed Original ResearchConceptsPostoperative radiation therapyStage IIOS benefitRadiation therapyUse of PORTMasaoka-Koga stage IIInternational Thymic Malignancy Interest GroupStage II thymomaOverall survival benefitPrimary end pointMultivariate Cox modelLonger overall survivalLog-rank testIndividual patient dataImproved OSParaneoplastic syndromeOverall survivalSurvival benefitOS ratesHistologic subtypePatient populationRetrospective databaseUnivariate analysisCox modelThymoma